{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.02 vs. cons $1.00",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.45B vs. cons $1.44B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Core sales growth",
      "prediction": "BEAT",
      "answer": "pred ~4.1% vs. cons 4.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 adjusted EPS guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$4.24 midpoint vs. cons $4.25 (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 core sales growth guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~3.75% midpoint vs. cons 3.8% (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted operating-margin expansion",
      "prediction": "UNCHANGED",
      "answer": "guide ~25 bps vs. cons 25 bps (FY26)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.5,
  "day5_path": "FADE",
  "day5_rationale": "A modest ~$0.02 EPS beat and ~10 bps core-growth upside should support an initial positive response, but unchanged FY26 EPS guidance of ~$4.24 versus ~$4.25 consensus leaves limited out-period revision upside; implied second-half EPS remains ~ $2.10 versus ~ $2.12 expected.",
  "day5_confidence": "MEDIUM"
}